{"id":470456,"date":"2023-08-23T20:25:11","date_gmt":"2023-08-24T03:25:11","guid":{"rendered":"https:\/\/nai500.com\/blog\/2023\/08\/1080%e4%ba%bf%e7%be%8e%e5%85%83-%e8%b5%9b%e9%81%93-%e5%a4%a7%e5%9e%8b%e7%9a%84%e7%94%9f%e7%89%a9%e5%88%b6%e8%8d%af%e8%82%a1%e7%a5%a8\/"},"modified":"2023-08-23T20:25:31","modified_gmt":"2023-08-24T03:25:31","slug":"1080%e5%84%84%e7%be%8e%e5%85%83-%e8%b3%bd%e9%81%93-%e5%a4%a7%e5%9e%8b%e7%9a%84%e7%94%9f%e7%89%a9%e8%a3%bd%e8%97%a5%e8%82%a1%e7%a5%a8","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hant\/blog\/2023\/08\/1080%e5%84%84%e7%be%8e%e5%85%83-%e8%b3%bd%e9%81%93-%e5%a4%a7%e5%9e%8b%e7%9a%84%e7%94%9f%e7%89%a9%e8%a3%bd%e8%97%a5%e8%82%a1%e7%a5%a8\/","title":{"rendered":"\u9019\u500b1080\u5104\u7f8e\u5143\u7684\u8cfd\u9053\u4e0a\uff0c\u5c07\u8dd1\u51fa\u4e0b\u4e00\u96bb\u5927\u578b\u7684\u751f\u7269\u88fd\u85e5\u80a1\u7968"},"content":{"rendered":"<h2>\u672a\u4f86\u5e7e\u5e74\uff0cNASH\u85e5\u7269\u7814\u767c\u9810\u8a08\u5c07\u6210\u70ba\u4e00\u5927\u71b1\u9580<\/h2>\n<p>\u6309\u7167\u6709\u4e9b\u4f30\u7b97\uff0c\u96d6\u7136\u73fe\u5728\u9084\u6c92\u6709\u4e0a\u5e02\u85e5\u7269\uff0c\u4f46\u975e\u9152\u7cbe\u6027\u8102\u80aa\u6027\u809d\u708e\uff08NASH\uff09\u85e5\u7269\u5e02\u5834\u7684\u898f\u6a21\u52302030\u5e74\u5c07\u9054\u5230\u9a5a\u4eba\u76841080\u5104\u7f8e\u5143\u3002\u4e0d\u96e3\u60f3\u50cf\uff0c\u8ab0\u80fd\u5403\u5230NASH\u85e5\u7269\u9019\u584a\u201c\u80a5\u8089\u201d\uff0c\u8db3\u4ee5\u8b93\u5b83\u6210\u9577\u70ba\u4e0b\u4e00\u96bb\u5927\u578b\u7684\u751f\u7269\u88fd\u85e5\u80a1\u7968\u3002<\/p>\n<p>\u4e8b\u5be6\u4e0a\uff0c\u5305\u62ec<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=AZN\">\u963f\u65af\u5229\u5eb7AstraZeneca\uff08NASDAQ:AZN\uff09<\/a>\u548c\u5409\u5229\u5fb7\u79d1\u5b78Gilead Sciences\uff08NASDAQ:GILD\uff09\u5728\u5167\u7684\u5f88\u591a\u88fd\u85e5\u5546\u6b64\u524d\u5c31\u66fe\u60f3\u5403\u9019\u584a\u80a5\u8089\uff0c\u4f46\u6700\u7d42\u90fd\u5012\u5728\u4e86\u5f8c\u671f\u81e8\u5e8a\u8a66\u9a57\u6216\u4e0a\u5e02\u5be9\u6279\u968e\u6bb5\u3002\u4e0d\u904e\uff0c\u9019\u4e26\u6c92\u6709\u963b\u6b62\u88fd\u85e5\u5546\u53bb\u958b\u62d3\u9019\u7247\u85cd\u6d77\uff0c\u4e00\u5927\u6279\u4e09\u671f\u8a66\u9a57\u4ee5\u53ca\u5176\u4ed6\u66f4\u65e9\u671f\u7684\u7814\u7a76\u9084\u5728\u706b\u71b1\u9032\u884c\u4e2d\u3002\u7d42\u6709\u4e00\u65e5\uff0c\u6703\u6709\u4eba\u62b5\u9054\u7d42\u9ede\u7dda\u3002<\/p>\n<p>\u4eca\u5929\u6211\u5011\u5c31\u4f86\u8aaa\u8aaaNASH\u85e5\u7269\u7684\u5e02\u5834\u524d\u666f\uff0c\u4ee5\u53ca\u9019\u500b\u8cfd\u9053\u4e0a\u7684\u73a9\u5bb6\u548c\u53ef\u80fd\u7684\u8d0f\u5bb6\u3002<\/p>\n<h2>NASH\u5e02\u5834\u7c21\u4ecb<\/h2>\n<p>\u7f8e\u570bNASH\u60a3\u8005\u4eba\u6578\u7d04\u70ba3500\u842c\uff0c\u800c\u5728\u5168\u7403\u7bc4\u570d\u5167\uff0c37%\u7684\u4eba\u6709\u53ef\u80fd\u6700\u7d42\u60a3\u4e0aNASH\u3002clinicaltrials.gov\u7684\u6578\u64da\u986f\u793a\uff0c\u81f3\u5c11\u6709102\u500b\u6b63\u5728\u9032\u884c\u6216\u5373\u5c07\u555f\u52d5\u7684NASH\u8a66\u9a57\u8655\u65bc\u4e8c\u671f\u6216\u4e09\u671f\uff0c\u662f\u76ee\u524d\u85e5\u7269\u958b\u767c\u6700\u71b1\u7684\u4e00\u500b\u9818\u57df\u3002<\/p>\n<p>\u6709\u95dc\u9019\u500b\u5e02\u5834\u7684\u9ad4\u91cf\uff0c\u5404\u5927\u6a5f\u69cb\u7684\u9810\u6e2c\u4e0d\u4e00\u3002\u6309\u7167Insight Partners\u7684\u9810\u6e2c\uff0c\u52302028\u5e74\uff0cNASH\u85e5\u7269\u5e02\u5834\u7684\u898f\u6a21\u6216\u5c07\u8d85\u904e240\u5104\u7f8e\u5143\u3002Research and Markets\u9810\u6e2c\u52302029\u5e74\uff0c\u8a72\u5e02\u5834\u6bcf\u5e74\u7684\u50f9\u503c\u81f3\u5c11\u5728840\u5104\u7f8e\u5143\uff0c\u53e6\u5916\u9084\u6709\u4eba\u5c07\u9019\u4e00\u9810\u6e2c\u6578\u5b57\u76f4\u63a5\u62c9\u5230\u4e86\u8d85\u904e1000\u5104\u7f8e\u5143\uff08\u52302030\u5e74\uff09\u3002<\/p>\n<p>\u5373\u4f7f\u6309\u7167\u6700\u4f4e\u7684\u4f30\u7b97\u6578\u5b57\uff0c\u9019\u500b\u5e02\u5834\u4e5f\u5bb9\u7d0d\u5f97\u4e0b\u591a\u5bb6\u85e5\u7269\u958b\u767c\u5546\u5171\u5b58\u3002\u63db\u53e5\u8a71\u8aaa\uff0c\u672a\u4f86\u5e7e\u5e74NASH\u9019\u500b\u8cfd\u9053\u4e0a\u5c07\u8dd1\u51fa\u591a\u500b\u8d0f\u5bb6\uff0c\u9ad4\u73fe\u5728\u6295\u8cc7\u7b56\u7565\u4e0a\u5c31\u662f\u6295\u8cc7\u8005\u53ef\u4ee5\u6253\u5305\u8cb7\u5165\u4e00\u4e9b\u5be6\u529b\u6700\u5f37\u7684\u751f\u7269\u88fd\u85e5\u80a1\u7968\u3002<\/p>\n<p>\u6700\u5f8c\u63d0\u4e00\u53e5\uff0c\u6309\u7167\u4eca\u5e746\u6708\u5e95\u65b0\u9054\u6210\u7684\u547d\u540d\u5171\u8b58\uff0cNASH\u66f4\u6e96\u78ba\u7684\u540d\u7a31\u61c9\u8a72\u662f\u4ee3\u8b1d\u76f8\u95dc\u8102\u80aa\u6027\u809d\u708e\uff08MASH\uff09\u3002<\/p>\n<h2>NASH\u8cfd\u9053\u4e0a\u7684\u4e3b\u8981\u7af6\u722d\u8005\u90fd\u6709\u8ab0\uff1f<\/h2>\n<p>\u9019\u500b\u8cfd\u9053\u5f88\u662f\u64c1\u64e0\uff0c\u9996\u5148\u662f\u5927\u578b\u88fd\u85e5\u5546\u8afe\u548c\u8afe\u5fb7Novo Nordisk\uff08NYSE:NVO\uff09\u3002\u8a72\u516c\u53f8\u6cbb\u7642NASH\u7684\u7d22\u99ac\u9b6f\u80bd\uff08\u5546\u54c1\u540dOzempic\uff09\u4e09\u671f\u8a66\u9a57\u6b63\u5728\u9032\u884c\u4e2d\uff0c\u6b64\u5916\u9084\u6709\u4e00\u500b\u4e8c\u671f\u9805\u76ee\u4ee5\u53ca\u5169\u500b\u8655\u65bc\u4e00\u671f\u7684\u5019\u9078\u7522\u54c1\u3002\u6b64\u5916\uff0c\u8a72\u516c\u53f8\u5df2\u7d93\u624b\u63e1\u5927\u91cf\u985e\u4f3cOzempic\u9019\u6a23\u975e\u5e38\u8cfa\u9322\u7684\u85e5\u54c1\uff0c\u56e0\u6b64\u98a8\u96aa\u76f8\u5c0d\u8f03\u4f4e\u3002<\/p>\n<p>\u53e6\u4e00\u500b\u4f4e\u98a8\u96aa\u7684\u9078\u64c7\u662f\u79ae\u4f86Eli Lilly and Co\uff08NYSE:LLY\uff09\u3002\u8a72\u516c\u53f8\u6b63\u5728\u7814\u7a76\u5169\u500b\u5206\u5225\u8655\u65bc\u4e8c\u671f\u548c\u4e00\u671f\u7684\u5019\u9078\u7522\u54c1\uff0c\u800c\u7121\u8ad6\u6210\u529f\u8207\u5426\uff0c\u5b83\u4e5f\u7121\u9700\u64d4\u5fc3\u8cc7\u91d1\u554f\u984c\uff0c\u56e0\u70ba\u8a72\u88fd\u85e5\u5546\u624b\u88e1\u4e5f\u6709\u5927\u91cf\u4e0a\u5e02\u85e5\u54c1\u30022018\u5e74\uff0c\u8a72\u516c\u53f8\u5c073\u500b\u5728\u7814\u85e5\u7269\u8cc7\u7522\u51fa\u552e\u7d66\u5c0f\u578b\u751f\u7269\u79d1\u6280\u516c\u53f8Terns Pharmaceuticals Inc\uff08NASDAQ:TERN\uff09\uff0c\u4e00\u98052b\/3\u671f\u8a66\u9a57\u9810\u8a08\u5c07\u57282024\u5e74\u555f\u52d5\u3002<\/p>\n<p>\u7b2c\u4e09\u5bb6\u958b\u767cNASH\u7642\u6cd5\u7684\u5f8c\u671f\u751f\u7269\u79d1\u6280\u516c\u53f8\u662fViking Therapeutics Inc\uff08NASDAQ:VKTX\uff09\uff0c\u8a72\u516c\u53f8\u6b63\u5728\u9032\u884c\u4e00\u98052b\u671f\u7684\u7814\u767c\u9805\u76ee\u3002<\/p>\n<p>\u4e0d\u904e\uff0c\u8ddd\u96e2NASH\u85e5\u7269\u7372\u6279\u4e0a\u5e02\u6700\u8fd1\u7684\u88fd\u85e5\u5546\u662fMadrigal Pharmaceuticals Inc\uff08NASDAQ:MDGL\uff09\u30027\u670817\u65e5\uff0c\u8a72\u516c\u53f8\u5ba3\u4f48\u5df2\u5411\u7f8e\u570b\u98df\u54c1\u85e5\u54c1\u76e3\u7ba1\u5c40\uff08FDA\uff09\u63d0\u4ea4\u4e86\u5019\u9078\u7522\u54c1\u7684\u4e0a\u5e02\u7533\u8acb\u3002\u5982\u679c\u7372\u6279\uff0c\u9019\u5c07\u662f\u7b2c\u4e00\u6b3e\u4e0a\u5e02\u7684NASH\u85e5\u7269\u3002\u4f46\u5982\u679c\u88ab\u5426\u6c7a\uff0cMadrigal\u80a1\u50f9\u5c07\u906d\u9047\u6bc0\u6ec5\u6027\u6253\u64ca\u3002\u56e0\u6b64\uff0c\u5982\u679c\u4f60\u7121\u6cd5\u627f\u53d7\u9019\u4e00\u98a8\u96aa\uff0c\u73fe\u5728\u4e0d\u8981\u8457\u6025\u8cb7\u5165\u3002<\/p>\n<p>\u5982\u679c\u4f60\u60f3\u6295\u8cc7NASH\u9019\u500b\u65b0\u8208\u7684\u5e02\u5834\uff0c\u8a18\u4f4f\u4e00\u9ede\uff0c\u751f\u7269\u79d1\u6280\u80a1\u7968\u7684\u98a8\u96aa\u8981\u9ad8\u65bc\u5927\u578b\u88fd\u85e5\u5546\u3002\u8003\u616e\u5230NASH\u85e5\u7269\u7684\u7814\u767c\u96e3\u5ea6\uff0c\u6211\u5011\u8981\u5c0d\u5019\u9078\u7522\u54c1\u6700\u7d42\u5931\u6557\u505a\u597d\u5fc3\u7406\u6e96\u5099\uff0c\u540c\u6642\u505a\u597d\u6295\u8cc7\u7684\u591a\u5143\u5316\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u672a\u4f86\u5e7e\u5e74\uff0cNASH\u85e5\u7269\u7814\u767c\u9810\u8a08\u5c07\u6210\u70ba\u4e00\u5927\u71b1\u9580 \u6309\u7167\u6709\u4e9b\u4f30\u7b97\uff0c\u96d6\u7136\u73fe\u5728\u9084\u6c92\u6709\u4e0a\u5e02\u85e5\u7269\uff0c\u4f46\u975e\u9152\u7cbe\u6027\u8102\u80aa\u6027\u809d\u708e\uff08NA [&hellip;]<\/p>\n","protected":false},"author":27,"featured_media":425563,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1522,431],"tags":[809,927,2001,564],"class_list":["post-470456","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-1522","category-trends-strategies-zh-hant","tag-809","tag-927","tag--zh-hant","tag-564","sectors-life-science-zh-hant","locations-us-zh-hant","exchange-nasdaq-zh-hant","exchange-nyse-zh-hant"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/470456","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/comments?post=470456"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/470456\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media\/425563"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media?parent=470456"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/categories?post=470456"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/tags?post=470456"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}